• The key challenges currently faced in lab-on-a-chip biochemical sensor developments are device reliability and power consumption.
• Point-of-care (POC) glucose biosensors play an important role in the management of blood sugar levels in patients with diabetes. Glucose biosensors still account for approximately 85% of the current world market which is estimated to be worth $5 billon.
• Ionic liquids (ILs) have evolved as a new type of solvent for biocatalysis, mainly due to their unique and tunable physical properties.
This item is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 License. View License
Funders:
This work is supported by a Marie Curie Actions International Re-integration Grant (IRG) (PIRG07-GA-2010-268365), Irish Research Council for Science, Engineering and Technology.
ID Code:
17894
Deposited On:
28 Mar 2013 14:35 by
Kevin Fraser
. Last Modified 13 Jan 2023 11:56